Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
708919
Created by
admin on Sat Dec 16 13:54:39 UTC 2023 , Edited by admin on Sat Dec 16 13:54:39 UTC 2023
|
||
|
NCI_THESAURUS |
C128037
Created by
admin on Sat Dec 16 13:54:39 UTC 2023 , Edited by admin on Sat Dec 16 13:54:39 UTC 2023
|
||
|
NCI_THESAURUS |
C129822
Created by
admin on Sat Dec 16 13:54:39 UTC 2023 , Edited by admin on Sat Dec 16 13:54:39 UTC 2023
|
||
|
FDA ORPHAN DRUG |
738120
Created by
admin on Sat Dec 16 13:54:39 UTC 2023 , Edited by admin on Sat Dec 16 13:54:39 UTC 2023
|
||
|
FDA ORPHAN DRUG |
863721
Created by
admin on Sat Dec 16 13:54:39 UTC 2023 , Edited by admin on Sat Dec 16 13:54:39 UTC 2023
|
||
|
FDA ORPHAN DRUG |
709919
Created by
admin on Sat Dec 16 13:54:39 UTC 2023 , Edited by admin on Sat Dec 16 13:54:39 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB14922
Created by
admin on Sat Dec 16 13:54:39 UTC 2023 , Edited by admin on Sat Dec 16 13:54:39 UTC 2023
|
PRIMARY | |||
|
0KVO411B3N
Created by
admin on Sat Dec 16 13:54:39 UTC 2023 , Edited by admin on Sat Dec 16 13:54:39 UTC 2023
|
PRIMARY | |||
|
C121775
Created by
admin on Sat Dec 16 13:54:39 UTC 2023 , Edited by admin on Sat Dec 16 13:54:39 UTC 2023
|
PRIMARY | |||
|
1858168-59-8
Created by
admin on Sat Dec 16 13:54:39 UTC 2023 , Edited by admin on Sat Dec 16 13:54:39 UTC 2023
|
PRIMARY | |||
|
10553
Created by
admin on Sat Dec 16 13:54:39 UTC 2023 , Edited by admin on Sat Dec 16 13:54:39 UTC 2023
|
PRIMARY | |||
|
FG-151
Created by
admin on Sat Dec 16 13:54:39 UTC 2023 , Edited by admin on Sat Dec 16 13:54:39 UTC 2023
|
PRIMARY | |||
|
Tislelizumab
Created by
admin on Sat Dec 16 13:54:39 UTC 2023 , Edited by admin on Sat Dec 16 13:54:39 UTC 2023
|
PRIMARY |
ACTIVE MOIETY